Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q6FUJ7

Entry ID Method Resolution Chain Position Source
AF-Q6FUJ7-F1 Predicted AlphaFoldDB

No variants for Q6FUJ7

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q6FUJ7

No associated diseases with Q6FUJ7

9 regional properties for Q6FUJ7

Type Name Position InterPro Accession
repeat HAT (Half-A-TPR) repeat 46 - 77 IPR003107-1
repeat HAT (Half-A-TPR) repeat 313 - 348 IPR003107-2
repeat HAT (Half-A-TPR) repeat 458 - 494 IPR003107-3
repeat HAT (Half-A-TPR) repeat 496 - 551 IPR003107-4
repeat HAT (Half-A-TPR) repeat 589 - 623 IPR003107-5
repeat HAT (Half-A-TPR) repeat 628 - 664 IPR003107-6
repeat HAT (Half-A-TPR) repeat 707 - 741 IPR003107-7
repeat HAT (Half-A-TPR) repeat 743 - 777 IPR003107-8
repeat Tetratricopeptide repeat 445 - 472 IPR019734

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

6 GO annotations of cellular component

Name Definition
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
Prp19 complex A protein complex consisting of Prp19 and associated proteins that is involved in the transition from the precatalytic spliceosome to the activated form that catalyzes step 1 of splicing, and which remains associated with the spliceosome through the second catalytic step. It is widely conserved, found in both yeast and mammals, though the exact composition varies. In S. cerevisiae, it contains Prp19p, Ntc20p, Snt309p, Isy1p, Syf2p, Cwc2p, Prp46p, Clf1p, Cef1p, and Syf1p.
U2-type catalytic step 1 spliceosome A spliceosomal complex that is formed by the displacement of the U1 and U4 snRNPs from the precatalytic spliceosome; the U2, U5 and U6 snRNPs remain associated with the mRNA. This complex, sometimes called the activated spliceosome, is the catalytically active form of the spliceosome, and includes many proteins in addition to those found in the U2, and U5 and U6 snRNPs.
U2-type catalytic step 2 spliceosome A spliceosomal complex that contains the U2, U5 and U6 snRNPs bound to a splicing intermediate in which the first catalytic cleavage of the 5' splice site has occurred. The precise subunit composition differs significantly from that of the catalytic step 1, or activated, spliceosome, and includes many proteins in addition to those found in the U2, U5 and U6 snRNPs.
U2-type post-mRNA release spliceosomal complex A spliceosomal complex that is formed following the release of the spliced product from the post-spliceosomal complex and contains the excised intron and the U2, U5 and U6 snRNPs.
U2-type prespliceosome A spliceosomal complex that is formed by association of the 5' splice site with the U1 snRNP, while the branch point sequence is recognized by the U2 snRNP. The prespliceosome includes many proteins in addition to those found in the U1 and U2 snRNPs. Commitment to a given pair of 5' and 3' splice sites occurs at the time of prespliceosome formation.

No GO annotations of molecular function

Name Definition
No GO annotations for molecular function

1 GO annotations of biological process

Name Definition
generation of catalytic spliceosome for first transesterification step Formation of a catalytic spliceosome complex ready to perform the first splicing reaction. This occurs by an ATP-dependent conformational change of the pre-catalytic spliceosome.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MADIDQYILD DSDIAFEYEL QKSPSVEVWQ RYIAHWEAQV CEDGVRSARH ILWLYERMVT
70 80 90 100 110 120
QFPTLTVWEQ YIGWFRRQYK LDQYLDTFKL YERCINSVKG PLGVFAVEVM LFCISTFDLD
130 140 150 160 170 180
IIMKGLQLVL HRCNKDEVER IWNIVLGFAL EHVLPSEEGP NNIDFSAFND RNYEDLRLDI
190 200 210 220 230 240
YKLLFLGGDQ TEIEDDEEDE DVDKWTASLL RYYLQVANED KYDETLRLLI RTKDIKIIKE
250 260 270 280 290 300
CFDLYIFNDK TGKNNRESKK EYDFDLYIYY LDTLDKLRLD KDYKSVFDNL LEKYPQHRVL
310 320 330 340 350 360
LTLKLADFHM KRADFDKMEK VLTKALSETV KTNEFIAIYT YHVNFEQAYV ETIFDEMRDD
370 380 390 400 410 420
PEIQVQKKWK SEMDDHLIIL GDLTSRYHLL VNDLKIRQNP NSVSNWLERT TLFEDFDKKC
430 440 450 460 470 480
EVFVEAIKTI DPIKVKDKEY GMLGKLWCDY AKVYWSNKSY EEARTIYESA TKVPFPDLQD
490 500 510 520 530 540
LEIVWHTWAV NEFQIHNIER ALKILRKALT VPPSYESIID RFKSENRRLP SQTILFTSKR
550 560 570 580 590 600
LWNYYIDLLE SIPTIDANDV IRAYDTLMTL KLITPVGILN YATFLKQNNN LHGSLQVYEK
610 620 630 640 650 660
GINMFPPEIC YELWTLLLDE VMEPAHQATK ERIRELFEQC LQQLGNTDIN INSIYVKYSD
670 680 690 700 710 720
FEIHNKLFSR AIDLLMSGAR RPYTNKEQLK QRVDLWESAI SKCEEFLGPD SLRQLLSECI
730 740 750 760 770 780
QELPNSKAIT YVLKFTKLEM SLSDYTRARE LLQYGAQLLP PIKNEELWGL WEQFELEHGD
790 800 810 820 830
KSYYKEMLLL KQKLEKEMKV DTEEVSKGQG NVQFVASSVK NQEAKTNPDE IEIDI